United States Anti-Doping Agency Reauthorization Act Public Law 113–280 United States Anti-Doping Agency Reauthorization Act 280 113–280 Statute Compilation United States House of Representatives Office of the Legislative Counsel text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. GPO Statute Compilations USLM converter, version 20210527.1 2021-10-15 United States Anti-Doping Agency Reauthorization Act 11463 113 2014-12-18 United States Anti-Doping Agency Reauthorization Act [(Public Law 113–280)] [This law has not been amended] [Currency: This publication is a compilation of the text of Public Law 113-280. It was last amended by the public law listed in the As Amended Through note above and below at the bottom of each page of the pdf version and reflects current law through the date of the enactment of the public law listed at https://www.govinfo.gov/app/collection/comps/] [Note: While this publication does not represent an official version of any Federal statute, substantial efforts have been made to ensure the accuracy of its contents. The official version of Federal law is found in the United States Statutes at Large and in the United States Code. The legal effect to be given to the Statutes at Large and the United States Code is established by statute (1 U.S.C. 112, 204).]
AN ACTTo reauthorize the United States Anti-Doping Agency, and for other purposes.Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. [21 U.S.C. 2001 note] SHORT TITLE. This Act may be cited as the “United States Anti-Doping Agency Reauthorization Act”.
SEC. 2. PROHIBIT PERFORMANCE-ENHANCING METHODS. Section 701 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C. 2001) is amended— (1) in subsection (a), by striking paragraph (4); and (2) in subsection (b)— (A) in paragraph (1), by inserting “and be recognized worldwide as the independent national anti-doping organization for the United States” after “Committee”; (B) in paragraph (2), by striking “, or performance-enhancing genetic modifications accomplished through gene-doping” and inserting “or prohibited performance-enhancing methods adopted by the Agency”; (C) in paragraph (3), by striking “, or performance-enhancing genetic modifications accomplished through gene-doping” and inserting “or prohibited performance-enhancing methods adopted by the Agency”; (D) in paragraph (4), by striking “and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and” and inserting “, and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency.”; and (E) by striking paragraph (5).
SEC. 3. AUTHORIZATION OF APPROPRIATIONS. Section 703 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C. 2003) is amended to read as follows:
“SEC. 703. AUTHORIZATION OF APPROPRIATIONS “There are authorized to be appropriated to the United States Anti-Doping Agency— “(1) for fiscal year 2014, $11,300,000; “(2) for fiscal year 2015, $11,700,000; “(3) for fiscal year 2016, $12,300,000; “(4) for fiscal year 2017, $12,900,000; “(5) for fiscal year 2018, $13,500,000; “(6) for fiscal year 2019, $14,100,000; and “(7) for fiscal year 2020, $14,800,000.”
.